MedTrace Logo

Randomized Trial of a Quality Improvement Intervention to Decrease D2B Time in Primary PCI for AMI

NCT01625104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 882

Last updated 2017-12-15

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to assess whether an aggressive quality improvement intervention strategy will decrease time from hospital presentation to first balloon inflation in non-transfer patients with acute ST segment elevation MI (STEMI) treated with primary percutaneous coronary intervention (PCI). Twelve hospitals in Michigan were randomized to either aggressive intervention or control. The intervention consisted of Grand Rounds at each hospital, sharing of best practices, and coordinating center staff working closely with staff at each intervention hospital to discuss solutions to barriers to rapid treatment for STEMI patients.

Conditions

  • STEMI

Interventions

OTHER

Non Intervention

Business as usual

OTHER

Agressive Intervention Process Improvement Strategies

Sponsors & Collaborators

Principal Investigators

  • Mauro Moscucci, M.D. · University of Michigan

  • Eva M Kline-Rogers, MS, RN · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2006-02-28
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01625104 on ClinicalTrials.gov